Riskpilot← Back to searchSign inGet full accessNEMUS TØNSBERG HELSEKLINIKK AS
ASActiveOrg 9140151542Etg Kjellengveien 2C, 3125 TønsbergTraditional, complementary and alternative medicine activities · NACE 8696Est. 20141 employees
Revenue 2024
NOK 4,2M
+10% vs 2023
EBITDA margin
3.0%
+547% vs 2023
Equity ratio
21.2%
Financial strength
Net profit 2024
NOK 77K
+58% vs 2023
| Revenue | NOK 4,2M | +10% |
| EBITDA | NOK 126K | +547% |
| Net profit | NOK 77K | +58% |
| Total assets | NOK 1,5M | +6% |
| Equity | NOK 325K | +31% |
| Employees | 1 | — |
Legal name
NEMUS TØNSBERG HELSEKLINIKK AS
Org number
914015154
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
18. august 2014
Share capital
NOK 510 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Helsetjenester, herunder kiropraktor, fysioterapi, massør, lege, akupunktur, gestalterapi og coaching tjenester
Address
2Etg Kjellengveien 2C, 3125 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 053 | 3 130 | 3 567 | 3 815 | 4 215 |
| Staff expenses | −164 | −188 | −188 | −193 | −55 |
| EBITDA | 105 | −154 | −20 | 19 | 126 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 105 | −154 | −20 | 19 | 126 |
| Net financials | −11 | −13 | −27 | 29 | −49 |
| Profit before tax | 94 | −167 | −48 | 49 | 77 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 94 | −167 | −48 | 49 | 77 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 027 | 824 | 1 414 | 1 447 | 1 530 |
| Equity | 414 | 247 | 199 | 247 | 325 |
| Long-term debt | 415 | 257 | 631 | 698 | 656 |
| Short-term debt | 198 | 320 | 584 | 501 | 550 |
| Total debt | 613 | 577 | 1 215 | 1 199 | 1 205 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20202024
Equity ratio
21.2%
This company
38.2%
Market median
-45% vs market
20202024
Return on equity
23.8%
This company
18.4%
Market median
+29% vs market
20202024
Net profit margin
1.8%
This company
8.1%
Market median
-78% vs market
20202024
Asset turnover
2.75×
This company
1.12×
Market median
+146% vs market
20202024
Debt / equity
3.71×
This company
0.62×
Market median
-498% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ML Chief Executive Officer | Chief Executive Officer | 2020 |
TS Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 42.24% | 42.24% | 2023 | |
| Company | 41.29% | 41.29% | 2023 | |
| Company | 16.47% | 16.47% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Larsen Helse As
NEMUS TØNSBERG HELSEKLINIKK AS Board members of NEMUS TØNSBERG HELSEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Le Dous Bruun | Chief Executive Officer | 0 companies |
| Tim Sparchholz | Chief Executive Officer | 0 companies |
| Joakim Axel Hertel | Board of Directors | 0 companies |
| Otto Torvik | Chairman | 0 companies |
| Ole Kristoffer Larsen | Board of Directors | 0 companies |